Lopes-Pacheco M[au] - Search Results

Year	Number of Results
2013	1
2014	4
2015	5
2016	6
2017	3
2018	8
2019	9
2020	5
2021	8
2022	1

1

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.

Lopes-Pacheco M. Lopes-Pacheco M. Front Pharmacol. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662. eCollection 2019. Front Pharmacol. 2020. PMID: 32153386 Free PMC article. Review.

2

Cell-Based Therapy for Silicosis.

Lopes-Pacheco M, Bandeira E, Morales MM. Lopes-Pacheco M, et al. Stem Cells Int. 2016;2016:5091838. doi: 10.1155/2016/5091838. Epub 2016 Mar 15. Stem Cells Int. 2016. PMID: 27066079 Free PMC article. Review.

3

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis.

Lopes-Pacheco M, Pedemonte N, Kicic A. Lopes-Pacheco M, et al. Front Pharmacol. 2019 Nov 29;10:1440. doi: 10.3389/fphar.2019.01440. eCollection 2019. Front Pharmacol. 2019. PMID: 31849681 Free PMC article. No abstract available.

4

Current understanding of the immunosuppressive properties of mesenchymal stromal cells.

de Castro LL, Lopes-Pacheco M, Weiss DJ, Cruz FF, Rocco PRM. de Castro LL, et al. Among authors: lopes pacheco m. J Mol Med (Berl). 2019 May;97(5):605-618. doi: 10.1007/s00109-019-01776-y. Epub 2019 Mar 22. J Mol Med (Berl). 2019. PMID: 30903229 Review.

5

Discovery of CFTR modulators for the treatment of cystic fibrosis.

Lopes-Pacheco M, Pedemonte N, Veit G. Lopes-Pacheco M, et al. Expert Opin Drug Discov. 2021 Aug;16(8):897-913. doi: 10.1080/17460441.2021.1912732. Epub 2021 Apr 13. Expert Opin Drug Discov. 2021. PMID: 33823716 Review.

6

Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis.

Pinto MC, Silva IAL, Figueira MF, Amaral MD, Lopes-Pacheco M. Pinto MC, et al. Among authors: lopes pacheco m. J Exp Pharmacol. 2021 Jul 23;13:693-723. doi: 10.2147/JEP.S255377. eCollection 2021. J Exp Pharmacol. 2021. PMID: 34326672 Free PMC article. Review.

7

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis.

Lopes-Pacheco M. Lopes-Pacheco M. Front Pharmacol. 2016 Sep 5;7:275. doi: 10.3389/fphar.2016.00275. eCollection 2016. Front Pharmacol. 2016. PMID: 27656143 Free PMC article. Review.

8

Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies.

Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, Morales MM, Caruso Neves C, Rocco PRM. Lopes-Pacheco M, et al. Front Physiol. 2021 Jan 28;12:593223. doi: 10.3389/fphys.2021.593223. eCollection 2021. Front Physiol. 2021. PMID: 33584343 Free PMC article. Review.

9

Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?

da Silva KN, Gobatto ALN, Costa-Ferro ZSM, Cavalcante BRR, Caria ACI, de Aragão França LS, Nonaka CKV, de Macêdo Lima F, Lopes-Pacheco M, Rocco PRM, de Freitas Souza BS. da Silva KN, et al. Among authors: lopes pacheco m. Stem Cell Res Ther. 2021 Jul 27;12(1):425. doi: 10.1186/s13287-021-02502-7. Stem Cell Res Ther. 2021. PMID: 34315546 Free PMC article. Review.

10

Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives.

Abreu SC, Lopes-Pacheco M, Weiss DJ, Rocco PRM. Abreu SC, et al. Among authors: lopes pacheco m. Front Cell Dev Biol. 2021 Feb 15;9:600711. doi: 10.3389/fcell.2021.600711. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33659247 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results